FDA Envisioning the Future for Biological Products
Archive
Today, the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) launched the “Envisioning the Future for Biological Products” Crowdsourcing Campaign. As part of a range of activities to keep pace with the rapidly evolving technical and scientific developments impacting biological products, CBER is exploring this interactive crowdsourcing platform to leverage knowledge, perspectives, and expertise from a diverse group of organizations and individuals.
